| Pharmaceutical active ingredients: |
| AcetaminophenCarisoprodol |
| Available forms, composition and doses of Algiseda: |
| N / A |
| Algiseda medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| M03BA52 - Carisoprodol, combinations excluding psycholeptics |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Instituto Sanitas |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Nasaliv | Acetaminophen; Carbinoxamine Maleate; Phenylephrine | Uniao Quimica Farmaceutica Nacional |
| Co-Tylenol | Acetaminophen; Carbinoxamine Maleate; Phenylephrine Hydrochloride | Johnson & Johnson; F. Uhlmann-Eyraud |
| Naldecon Solution | Acetaminophen; Carbinoxamine Maleate; Phenylephrine Hydrochloride | Bristol-Myers Squibb; Apothecon |
| Naldecon Tablets | Acetaminophen; Carbinoxamine Maleate; Phenylephrine Hydrochloride | Bristol-Myers Squibb |
| Humex Capsules | Acetaminophen; Carbinoxamine Maleate; Phenylpropanolamine Hydrochloride | Urgo Laboratoires |
| Cariso-Co | Acetaminophen; Carisoprodol | Picharn |
| Caritasone | Acetaminophen; Carisoprodol | Pharma Square |
| Lagaflex | Acetaminophen; Carisoprodol | Lagap |
| Muscelax | Acetaminophen; Carisoprodol | B L Hua |
| Polixan | Acetaminophen; Carisoprodol | Polipharm, Thailand |